{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:14:39Z","timestamp":1793103279789,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.humpath.2015.07.017","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T23:34:37Z","timestamp":1438904077000},"page":"1760-1768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy"],"prefix":"10.1016","volume":"46","author":[{"given":"Cristina","family":"Chimenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Scopelliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Vulpis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tafani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Villanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Verardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"De Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Frustaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.07.017_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"issue":"Suppl. 2","key":"10.1016\/j.humpath.2015.07.017_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.humpath.2015.07.017_bb0015","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","article-title":"Cardiac manifestations of Anderson-Fabry disease in heterozygous females","volume":"40","author":"Kampmann","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.humpath.2015.07.017_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2015.07.017_bb0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late-onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.humpath.2015.07.017_bb0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.humpath.2015.07.017_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"key":"10.1016\/j.humpath.2015.07.017_bb0040","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2353\/ajpath.2008.070576","article-title":"Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease","volume":"172","author":"Chimenti","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2015.07.017_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carpath.2009.05.003","article-title":"A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy","volume":"19","author":"Sheppard","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.humpath.2015.07.017_bb0050","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2015.07.017_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","article-title":"Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease","volume":"31","author":"Brakch","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.humpath.2015.07.017_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.humpath.2015.07.017_bb0065","doi-asserted-by":"crossref","first-page":"e36373","DOI":"10.1371\/journal.pone.0036373","article-title":"Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease","volume":"7","author":"Namdar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.07.017_bb0070","first-page":"226","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy","volume":"2012","author":"Biancini","year":"1822","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2015.07.017_bb0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.0000154550.15963.80","article-title":"Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency","volume":"111","author":"Bodary","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.humpath.2015.07.017_bb0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.humpath.2015.07.017_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.2013.520","article-title":"Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease","volume":"86","author":"Shu","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.humpath.2015.07.017_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2015.07.017_bb0095","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.humpath.2011.09.020","article-title":"Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study","volume":"43","author":"Chimenti","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.07.017_bb0100","series-title":"Positive pixel count algorithm user's guide","first-page":"5","author":"Aperio Technologies","year":"2009"},{"key":"10.1016\/j.humpath.2015.07.017_bb0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/his.12256","article-title":"Decreased CD1a(+), CD83(+) and factor XIIIa(+) dendritic cells in cervical lymph nodes and palatine tonsils of AIDS patients","volume":"64","author":"Gondak","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2015.07.017_bb0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1369\/0022155413477661","article-title":"A comparison between manual and automated evaluations of tissue microarray patterns of protein expression","volume":"61","author":"Alvarenga","year":"2013","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.humpath.2015.07.017_bb0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.RES.0000093985.76901.AF","article-title":"Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure","volume":"93","author":"Chimenti","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.humpath.2015.07.017_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCHEARTFAILURE.108.769729","article-title":"Angina in Fabry disease reflects coronary small vessel disease","volume":"1","author":"Chimenti","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.humpath.2015.07.017_bb0125","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/01.CIR.0000061952.27445.A0","article-title":"Early detection of Fabry cardiomyopathy by tissue Doppler imaging","volume":"107","author":"Pieroni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.humpath.2015.07.017_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ejechocard\/jer109","article-title":"Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease","volume":"12","author":"Zamorano","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.humpath.2015.07.017_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1011453809750","article-title":"The role of nitric oxide in the failing heart","volume":"6","author":"Paulus","year":"2001","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.humpath.2015.07.017_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cardiores.2005.03.025","article-title":"Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells","volume":"67","author":"Borb\u00e9ly","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.humpath.2015.07.017_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.freeradbiomed.2011.01.003","article-title":"Redox signaling in cardiac myocytes","volume":"50","author":"Santos","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.humpath.2015.07.017_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11883-014-0452-y","article-title":"8-hydroxy-2\u2032-deoxyguanosine and cardiovascular disease: a systematic review","volume":"16","author":"Kroese","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.humpath.2015.07.017_bb0155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1253\/circj.70.1001","article-title":"Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure","volume":"70","author":"Kono","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.humpath.2015.07.017_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/hh1501.094115","article-title":"Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy","volume":"89","author":"Cesselli","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.humpath.2015.07.017_bb0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2011.06.007","article-title":"Higher apoptotic state in Fabry disease peripheral blood mononuclear cells: effect of globotriaosylceramide","volume":"104","author":"De Francesco","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.humpath.2015.07.017_bb0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jcb.1198","article-title":"Multiple role of reactive oxygen species in the arterial wall","volume":"82","author":"Napoli","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.humpath.2015.07.017_bb0175","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2015.07.017_bb0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF01799411","article-title":"Decreased activity of the mitochondrial ATP-synthase in fibroblasts from children with late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Das","year":"1996","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.humpath.2015.07.017_bb0185","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1139\/o88-153","article-title":"Lysosphingolipids and mitochondrial function. II. Deleterious effects of sphingosylphosphorylcholine","volume":"66","author":"Strasberg","year":"1988","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.humpath.2015.07.017_bb0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.01.011","article-title":"Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts","volume":"82","author":"Lucke","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.humpath.2015.07.017_bb0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2423(09)49003-6","article-title":"Biochemical basis of Fabry disease with emphasis on mitochondrial function and protein trafficking","volume":"49","author":"Das","year":"2009","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.humpath.2015.07.017_bb0200","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1582-4934.2008.00445.x","article-title":"The peroxynitrite evoked contractile depression can be partially reversed by antioxidants in human cardiomyocytes","volume":"13","author":"Hertelendi","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2015.07.017_bb0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jmri.20162","article-title":"Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study","volume":"20","author":"Moore","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.humpath.2015.07.017_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.hfc.2011.11.002","article-title":"Nitric oxide modulation as a therapeutic strategy in heart failure","volume":"8","author":"Taylor","year":"2012","journal-title":"Heart Fail Clin"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:19Z","timestamp":1758645379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0046817715002804"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.07.017","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}